SynthesisProstate cancer and prostatic diseases2024

Role of enzalutamide in primary and recurrent non-metastatic hormone sensitive prostate cancer: a systematic review of prospective clinical trials.

Mohamed Shelan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.